SQUAMOUS CELL CARCINOMA OF HEAD AND NECK
Clinical trials for SQUAMOUS CELL CARCINOMA OF HEAD AND NECK explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CARCINOMA OF HEAD AND NECK trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CARCINOMA OF HEAD AND NECK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to shrink tumors before cancer surgery
Disease control Not yet recruitingThis study is testing a three-drug combination given before surgery to people with advanced but removable oral or larynx cancer. The goal is to see if this treatment can shrink or even eliminate the tumor before it is surgically removed, which may lead to better long-term results…
Matched conditions: SQUAMOUS CELL CARCINOMA OF HEAD AND NECK
Phase: PHASE2 • Sponsor: National Medical Research Radiological Centre of the Ministry of Health of Russia • Aim: Disease control
Last updated Apr 01, 2026 21:26 UTC
-
New Skin-Injection drug joins fight against head & neck cancer
Disease control Not yet recruitingThis early-stage study is testing if adding an experimental drug called CADI-05 to a standard immunotherapy (pembrolizumab) can better prepare the immune system to fight head and neck cancer before surgery. The main goals are to check the safety of this combination and see if it …
Matched conditions: SQUAMOUS CELL CARCINOMA OF HEAD AND NECK
Phase: PHASE1 • Sponsor: Fox Chase Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
New hope for Tough-to-Treat head and neck cancer: trial tests chemo timing
Disease control Not yet recruitingThis study aims to find the better way to give a chemotherapy drug called 5-FU to people with advanced head and neck cancer that has worsened after two standard treatments. It will compare giving the drug for two days every two weeks versus four days every three weeks. The main g…
Matched conditions: SQUAMOUS CELL CARCINOMA OF HEAD AND NECK
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
Custom vaccine tailored to Patient's tumor enters first human test
Disease control Not yet recruitingThis is a first-in-human safety study for a personalized cancer vaccine called PANDA-VAC. It will be given alongside the immunotherapy drug pembrolizumab to 6 patients with advanced squamous cell lung cancer or head and neck cancer. The vaccine is custom-made for each patient bas…
Matched conditions: SQUAMOUS CELL CARCINOMA OF HEAD AND NECK
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Feb 20, 2026 14:37 UTC
-
New program aims to speed up cancer care for emergency room patients
Knowledge-focused Not yet recruitingThis pilot study is testing a community health support program designed to help head and neck cancer patients who first go to the emergency room. The program connects patients with a specialist who helps them overcome common barriers like transportation or insurance issues to get…
Matched conditions: SQUAMOUS CELL CARCINOMA OF HEAD AND NECK
Phase: NA • Sponsor: University of Tennessee • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC